Table 1

Description of population before and after the use of robotic surgery for ovarian cancer

Pre-robotic era: laparotomy only
(n=22)
Robotic era: laparotomy + robotics
(n=91)
P value
Age, mean (SD)65.4 (9.2)64.1 (13.5)0.98
BMI, mean (SD)27.3 (5.8)26.7 (6.3)0.52
ASA0.41*
 12 (9.1%)3 (3.3%)
 211 (50.0%)54 (59.3%)
 37 (31.8%)33 (36.3%)
 Unknown2 (9.1%)1 (1.1%)
Stage1.00
 III17 (77.3%)71 (78.0%)
 IV5 (22.7%)20 (22.0%)
Grade0.005
 10 (0%)1 (1.1%)
 24 (18.2%)1 (1.1%)
 318 (81.8%)89 (97.8%)
Histology0.37
 Serous19 (86.4%)79 (86.8%)
 Endometrioid1 (4.6%)3 (3.3%)
 Clear cell0 (0%)5 (5.5%)
 Carcinosarcoma0 (0%)1 (1.1%)
 Adenosquamous1 (4.6%)0 (0%)
 Not defined1 (4.6%)3 (3.3%)
Follow-up time (months)0.56
 Mean (SD)46.0 (29.5)38.2 (19.1)
 Median (range)36.2 (9.0–104.3)37.0 (5.6–91.4)
  • Data are presented as n (%) unless stated otherwise.

  • *Statistical significance excludes unreported/missing data.

  • ASA, American Society of Anesthesiologists physical status classification system; BMI, body mass index (kg/m2).